Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
46.13
-1.29 (-2.72%)
At close: Feb 21, 2025, 4:00 PM
46.50
+0.37 (0.80%)
After-hours: Feb 21, 2025, 5:42 PM EST
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Soleno Therapeutics stock have an average target of 71.2, with a low estimate of 67 and a high estimate of 74. The average target predicts an increase of 54.35% from the current stock price of 46.13.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 2, 2024.
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Reiterates $72 | Buy | Reiterates | $72 | +56.08% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +51.75% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +51.75% | Nov 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $65 → $73 | Buy | Maintains | $65 → $73 | +58.25% | Oct 28, 2024 |
| Stifel | Stifel | Strong Buy Maintains $59 → $74 | Strong Buy | Maintains | $59 → $74 | +60.42% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
36.57M
EPS This Year
-4.31
from -2.36
EPS Next Year
-2.82
from -4.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 64.1M | 240.7M |
| Avg | n/a | 36.6M | 155.0M |
| Low | n/a | 6.8M | 34.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 558.1% |
| Avg | - | - | 323.8% |
| Low | - | - | -6.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.90 | -1.80 | 0.90 |
| Avg | -4.31 | -2.82 | -1.20 |
| Low | -4.93 | -4.99 | -2.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.